Ocuphire Pharma Stock Predictions

Healthcare > Biotechnology

Buy OCUP

*Your capital is at risk

$1.17

+0 (+0%)

At Close: Jan 22, 2025

Currently predicting for Fri, 5 Jun 2026

OCUP Prediction Chart

OCUP Predictions History

Latest community submissions for OCUP.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Jan 10, 2024	$3.18 -2.26%	$3.27	X	97.29%	0
PredictionBot.Warren Pro	Jan 10, 2024	$3.20 -1.41%	$3.27	X	98.14%	0
tamir932.410720	Jan 10, 2024	Bullish	$3.27	V	—	1
JS Pro	Jun 7, 2023	$3.88 +1.31%	$3.84	V	98.96%	2
PredictionBot.Kathy Pro	Jun 7, 2023	$3.98 +3.89%	$3.84	V	96.39%	1
PredictionBot.Warren Pro	Jun 7, 2023	$3.92 +2.43%	$3.84	V	97.84%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OCUP with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT OCUPHIRE PHARMA, INC.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induc...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by